pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
695bdaf0-e42e-4c58-b125-ab09a3742b1a
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-07 23:00:39
Income (reported)
$60,000
Expenses (reported)
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

AEGIS LLC

Contact
BETH ANNE COLE
Phone
+1 301-928-4388
Address
zip:20037, city:Washington, state:DC, street:1177 22nd Street NW Unit 4A

Client

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Biopharmaceutical industry trade association.

State
DC
Country
US
Effective date
2024-07-01

Issues lobbied + lobbyists

PHA — Pharmacy

Pharmacy Benefit Manager (PBM) issues and reform. 340B. IRA implementation. H.R.1492: Ensuring Pathways to Innovative Cures (EPIC) Act. Drug pricing. Most-Favored Nation (MFN) International reference pricing. H.R.5378 - Lower Costs, More Transparency Act. H.R.5376 - Share the Savings with Seniors Act. H.R.6283/S.1542 - DRUG Act. H.R.830 - HELP Copays Act.

Lobbyists: ms ANNE ELIZABETH ESPOSITO (covered position: Health Policy Coordinator, Energy and Commerce Committee; Health Policy Advisor, Health Subcommittee (Chairman Bilirakis))

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

General health care issues.

Lobbyists: ms ANNE ELIZABETH ESPOSITO

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page. Want to partner? Contact us.

Estimated value: $540/mo per user — but we made it free.